Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.072 0.1
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.076 0.2
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA AC220 GDSC1000 pan-cancer AAC -0.05 0.2
mRNA KIN001-244 GDSC1000 pan-cancer AAC -0.045 0.2
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA NG-25 GDSC1000 pan-cancer AAC -0.042 0.2
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA Bexarotene FIMM pan-cancer AAC -0.21 0.2
mRNA parbendazole CTRPv2 pan-cancer AAC -0.044 0.2
Download CSV